Recent Finacing
Recent Raise
NeoMend develops ProGEL, a two-component human serum albumin and PEG hydrogel sealant, deliverable by spray or injection for surgical wound closure, adhesion prevention, and arterial sealing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
